Schedule 13G ownership disclosure

Strongbridge Biopharma plc

Security class unavailable · CUSIP: G85347105

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,131,576
Percent of class
5.3400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-094580
Form type
SC 13G
Filer
Spetalen Eigil Stray
CIK
CIK 1666059
Filed
Feb 08, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub